A detailed history of Balentine LLC transactions in Insulet Corp stock. As of the latest transaction made, Balentine LLC holds 2,894 shares of PODD stock, worth $570,667. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,894
Previous 1,315 120.08%
Holding current value
$570,667
Previous $285,000 74.04%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$163.6 - $209.11 $258,324 - $330,184
1,579 Added 120.08%
2,894 $496,000
Q4 2023

Feb 09, 2024

BUY
$127.77 - $221.42 $168,017 - $291,167
1,315 New
1,315 $285,000
Q3 2020

Nov 02, 2020

SELL
$192.55 - $236.59 $1,540 - $1,892
-8 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$159.17 - $224.73 $1,273 - $1,797
8 New
8 $2,000
Q3 2019

Nov 15, 2019

SELL
$117.35 - $167.95 $821 - $1,175
-7 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$82.13 - $120.73 $574 - $845
7 New
7 $1,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $13.7B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.